Hyperthermia Inhibits Recombination Repair of Gemcitabine-Stalled Replication Forks
Open Access
- 15 August 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 106 (8)
Abstract
Gemcitabine is a potent nucleoside analogue against solid tumors, but development of drug resistance is a substantial problem. Removal of gemcitabine incorporated into DNA by repair mechanisms may contribute to resistance in chemo-refractory solid tumors. Human hepatocellular carcinoma (HCC) is usually very chemoresistant to gemcitabine. We treated HCC in vitro and in vivo (orthotopic murine model with human Hep3B or HepG2 xenografts, 7–10 CB17SCID mice per group) with gemcitabine. The role of homologous recombination repair proteins in repairing stalled replication forks was evaluated with hyperthermia exposure and cell-cycle analysis. The Student t-test was used for two-sample comparisons. Multiple group data were analyzed using one-way analysis of variance. All statistical tests were two-sided. We demonstrated that Mre11-mediated homologous recombination repair of gemcitabine-stalled replication forks is crucial to survival of HCC cells. Furthermore, we demonstrated inhibition of Mre11 by an exonuclease inhibitor or concomitant hyperthermia. In orthotopic murine models of chemoresistant HCC, the Hep3B tumor mass with radiofrequency plus gemcitabine treatment (mean ± SD, 180±91mg) was statistically significantly smaller compared with gemcitabine alone (661±419mg, P = .0063). This study provides mechanistic understanding of homologous recombination inhibiting-strategies, such as noninvasive radiofrequency field-induced hyperthermia, to overcome resistance to gemcitabine in refractory human solid tumors.Keywords
This publication has 31 references indexed in Scilit:
- Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibitionProceedings of the National Academy of Sciences, 2011
- Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11Cell, 2011
- More forks on the road to replication stress recoveryJournal of Molecular Cell Biology, 2011
- Noninvasive Radiofrequency Field Destruction of Pancreatic Adenocarcinoma Xenografts Treated with Targeted Gold NanoparticlesClinical Cancer Research, 2010
- Purified human BRCA2 stimulates RAD51-mediated recombinationNature, 2010
- Hyperthermia alters the interaction of proteins of the Mre11 complex in irradiated cellsCytometry Part A, 2010
- Exonuclease Function of Human Mre11 Promotes Deletional Nonhomologous End JoiningJournal of Biological Chemistry, 2009
- PARP‐1 transcriptional activity is regulated by sumoylation upon heat shockThe EMBO Journal, 2009
- PARP is activated at stalled forks to mediate Mre11‐dependent replication restart and recombinationThe EMBO Journal, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008